Long Term Oxygen Therapy in Patients With Interstitial Lung Disease

Role of LTOT in Pateints With ILD

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04089826

Enrollment

Registered

2019-09-13

Start date

2019-09-30

Completion date

2020-10-31

Last updated

2019-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interstitial Lung Disease, Long Term Oxygen Therapy

Brief summary

Study the effect of using long term oxygen therapy in patients with interstitial lung disease and chronic hypoxia

Detailed description

long term oxygen can be used in patients with interstitial lung disease with hypoxia and the aim of this study is to k ow whether this will improve life style , exercise tolerance in those patients

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Inclusion criteria

: * patients with ILD and hypoxia with SO2\<88 at room air and PO2 \< or equal 7.3k.pa or \< or equal 8 k.pa in presence of lower limb edema , pulmonary hypertension or polycythemia * age group 18 : 70

Exclusion criteria

: * Causes of chronic respiratory failure other than ILD.

Design outcomes

Primary

Measure	Time frame	Description
Dyspnea score improvement	Baseline	dyspnea by Modified Medical Research Counsel
Quality of life improvement	Baseline	Quality of life by st.George questionnaire

Contacts

Primary ContactAsmaa Mahmoud Mohamed Eltayeb

asmaaeltayeb34@gmail.com01114203879

Backup ContactAtef Farouk Elqarn

01006474200

Outcome results